Abstract:The death of a child is an uncommon occurrence and can be difficult for families to accept. Attempts by the healthcare team to discuss end-of-life issues can be so upsetting to families that they refuse to participate in the discussion. Even with diseases where an early death can be anticipated, such as Duchenne muscular dystrophy, the family is often reluctant to discuss end-of-life issues when the patient is relatively healthy, preferring to focus on the current health issues. In this article we discuss what… Show more
“…The neuroethical issue is particularly important within the decision-making conflict regarding the suspension of respiratory care. In accordance with many authors 19,20,25,55 , in dealing with patients that suffer from severe cognitive sequelae (cerebral malformations, persistent coma, cerebral palsy, and so forth), doctors felt less discomfort in recommending the suspension and omission of treatment procedures than when dealing with non-oncological illnesses that do not affect the patient cognitively, such as neurodegenerative muscular disorders 28,54,67 , cystic fibrosis 46 , and pulmonary insufficiency due to hemosiderosis 37 and so forth. However, with respect to chromosomopathies and/or cerebral malformations, other studies 12,76 defend the position that the diagnosis in and of itself is not sufficient to recommend the implementation of therapeutic restrictions.…”
Section: Current Treatments That Will Be Suspended/ Renouncedsupporting
confidence: 54%
“…Torres et al 69 elucidated that the removal of the patient's tubes, within the context of palliative care, must only occur after the patient has been off muscle relaxers, receives higher doses of sedatives or has had his ventilatory parameters decreased until the moment the tubes are removed and are substituted by some other less invasive respiratory care procedure, such as nasal oxygen cannulas. However, Penner et al 54 , upon studying a case of Duchenne muscular dystrophy, showed that it is not clear if mechanical ventilation within the patient's home via tracheostomy constitutes therapeutic obstinacy, or if it is simply a chronic form of care in the face of a severe and knowingly fatal disease.…”
Section: Current Treatments That Will Be Suspended/ Renouncedmentioning
Resumo As malformações cerebrais congênitas podem se apresentar de forma leve ou grave, podendo ser letais mesmo poucas horas após o nascimento. A partir de levantamento bibliográfico sistemático, verificou-se que, embora em tese sejam eticamente semelhantes suspender e renunciar a tratamento, tal equivalência não é percebida na prática por médicos e enfermeiros assistentes, nem pela população em geral, que tende a aceitar mais confortavelmente a renúncia que a suspensão de tratamentos. O diálogo com os pais é o procedimento que legitima a iniciativa médica de propor limitação terapêutica. Em conclusão, as malformações cerebrais graves resultam em contexto de terminalidade de vida, em que limitação ao suporte respiratório é o principal conflito enfrentado e ao qual se aplicam princípios bioéticos dos cuidados paliativos.
“…The neuroethical issue is particularly important within the decision-making conflict regarding the suspension of respiratory care. In accordance with many authors 19,20,25,55 , in dealing with patients that suffer from severe cognitive sequelae (cerebral malformations, persistent coma, cerebral palsy, and so forth), doctors felt less discomfort in recommending the suspension and omission of treatment procedures than when dealing with non-oncological illnesses that do not affect the patient cognitively, such as neurodegenerative muscular disorders 28,54,67 , cystic fibrosis 46 , and pulmonary insufficiency due to hemosiderosis 37 and so forth. However, with respect to chromosomopathies and/or cerebral malformations, other studies 12,76 defend the position that the diagnosis in and of itself is not sufficient to recommend the implementation of therapeutic restrictions.…”
Section: Current Treatments That Will Be Suspended/ Renouncedsupporting
confidence: 54%
“…Torres et al 69 elucidated that the removal of the patient's tubes, within the context of palliative care, must only occur after the patient has been off muscle relaxers, receives higher doses of sedatives or has had his ventilatory parameters decreased until the moment the tubes are removed and are substituted by some other less invasive respiratory care procedure, such as nasal oxygen cannulas. However, Penner et al 54 , upon studying a case of Duchenne muscular dystrophy, showed that it is not clear if mechanical ventilation within the patient's home via tracheostomy constitutes therapeutic obstinacy, or if it is simply a chronic form of care in the face of a severe and knowingly fatal disease.…”
Section: Current Treatments That Will Be Suspended/ Renouncedmentioning
Resumo As malformações cerebrais congênitas podem se apresentar de forma leve ou grave, podendo ser letais mesmo poucas horas após o nascimento. A partir de levantamento bibliográfico sistemático, verificou-se que, embora em tese sejam eticamente semelhantes suspender e renunciar a tratamento, tal equivalência não é percebida na prática por médicos e enfermeiros assistentes, nem pela população em geral, que tende a aceitar mais confortavelmente a renúncia que a suspensão de tratamentos. O diálogo com os pais é o procedimento que legitima a iniciativa médica de propor limitação terapêutica. Em conclusão, as malformações cerebrais graves resultam em contexto de terminalidade de vida, em que limitação ao suporte respiratório é o principal conflito enfrentado e ao qual se aplicam princípios bioéticos dos cuidados paliativos.
“…Two case series252 267 report on positive experiences of children and young adults with DMD in the formulation of life plans, regardless of the decision made about long-term ventilator assistance. A case study of a boy with DMD by Penner and colleagues268 describes the ethics of disclosure and emotionally charged challenges surrounding advance care plans.…”
“…Penner, Cantor, and Siegal [40] reported the determination of a young man with DMD who decided not to use his long-term ventilator. His mother was shocked and rejected his decision at first, but she later accepted this decision due to the medical team's efforts to include her in the end-of-life conversation.…”
Section: Parents' Intervention In the Development Of Self-determinatimentioning
The population of adults with Duchenne muscular dystrophy is increasing rapidly. However, information for individuals with DMD and their parents about the transition to adulthood is lacking; young adult sons and their parents may struggle to maintain smooth family functioning and well-being during this period. This study examined the process of change in parental behaviors during their son's transition. The participants were 18 parents with sons aged 15-30 years. Data were obtained from semi-structured interviews and analyzed using a grounded theory approach. Eleven categories of behaviors were identified across three domains: emotional, physical, and determination. The changes made by parents were directed toward becoming a back-up carer: letting go of some control but still being active participants in their sons' lives. We identified several issues important for well-being in the transition period: psychological support, the aging of the parents (the primary caregivers) and the concomitant emergency and specialized care needs, and parents' intervention in the self-determination of adult sons with DMD. The findings of this study may provide a rationale to advocate for policies to improve support for parents of sons with DMD transitioning to adulthood and provide information to help parents in their role as primary care providers.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.